Interesting study being planned for POTS with Efgartigimod. A monoclonal antibody fragment that binds other antibodies. Think of it like a pharmaceutical immunoadsorption without the extracorporeal circuit.
More info on the drug here ⬇️
www.argenx.com
More info on the study here ⬇️
Essentially demonstrates that at least one pharmaceutical company believes that POTS is autoimmune, with autoantibodies in nature.
More info on the drug here ⬇️
Efgartigimod
More info on the study here ⬇️
Essentially demonstrates that at least one pharmaceutical company believes that POTS is autoimmune, with autoantibodies in nature.